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ABSTRACT 
 
Helicobacter pylori infection is the main cause of chronic gastritis, gastric ulcers and 
gastric cancer. The gram-negative spirochete, which infects more than half of the world’s 
population, is recognized by the International Agency for Research on Cancer as a group 1 
carcinogen. The mechanism by which H. pylori induces carcinogenesis is believed to be its 
ability to cause chronic inflammation, creating an environment suitable to tumor initiation and 
progression. 
Many different strains of H. pylori exist, but those strains harboring the cag pathogenicity 
island (cagPAI) have been found to be more virulent, with more carcinomas associated with 
infection by these strains. Significantly, higher levels of H. pylori-initiated chronic gastritis is 
characterized by the cagPAI-dependent up-regulation of proinflammatory cytokines, which are 
largely mediated by the transcription factor nuclear factor (NF)-κB. The goal of this work is to 
better define the bacterial proteins and the cellular signaling molecules involved in H. pylori-
induced NF-κB activation. 
The H. pylori virulence factor CagA, encoded by the cagPAI, is injected into host cells 
via a type 4 secretion system, where it interacts with a number of different signaling pathways 
leading to inflammation and cell scattering. While a number of these interactions have been 
defined, the role of CagA in NF-κB activation and in immune response remains unclear. In this 
work, CagA is shown to be crucial in the activation of NF-κB by H. pylori infection. 
Once inside the cell, CagA utilizes host proteins to induce NF-κB activity. CagA 
associates with transforming growth factor β-activated kinase 1 (TAK1), a MAP kinase involved 
in the NF-κB, AP-1 and JNK signaling pathways, and enhances the polyubiquitination and 
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activation of the kinase. This lysine 63-linked ubiquitination is mediated by E3 ligase tumor 
necrosis factor receptor-associated factor 6 (TRAF6) and E2 Ubc13. These findings show that 
polyubiquitination of TAK1 regulates the activation of NF-κB, which in turn is used by H. 
pylori CagA for the H. pylori-induced inflammatory response. 
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CHAPTER 1 
BACKGROUND 
 
1.1 Helicobacter pylori and gastric cancer 
Helicobacter pylori is a Gram-negative spirochete which infects more than half of the 
world’s population. Infections are very common in undeveloped countries, likely due to water 
contamination and less sanitary living conditions. The bacterium colonizes the stomach of its 
host, where it attaches to the mucosal epithelia. Infection persists often for the lifetime of the 
host unless treatment is received. H. pylori is susceptible to most antibiotics, though resistance is 
becoming more common and triple or quadruple therapy consisting of two antibiotics, a proton 
pump inhibitor and bismuth is now used to eradicate the bacteria. 
There are many different strains of H. pylori, and a variety of pathogenicity factors 
produced by the different strains, creating a great variability in the bacteria’s ability to cause 
disease. Two of the most well studied pathogenicity factors are VacA and the cytotoxin-
associated gene pathogenicity island (cagPAI). VacA is an anion channel-forming cytotoxin 
named for its ability to fill infected cells with structures resembling swollen vacuoles (Iwamoto 
et al., 1999). Perhaps most importantly, it also has properties which allow the bacteria to evade 
the immune response; VacA can inhibit both CD8+ and CD4+ T lymphocyte and B lymphocyte 
proliferation, critical steps in initiation of the immune response (Torres et al., 2007). While all H. 
pylori strains express some type of VacA, it is hypothesized that bacteria which possess the more 
active allele combinations may be more adept at persistent colonization of their hosts (Polk and 
Peek, 2010). The cagPAI is a 40kbp fragment of DNA containing 27 potential coding regions 
(Censini et al., 1996) which is found in many strains of H. pylori. It encodes a type 4 secretion 
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system (T4SS) and the virulence factor CagA. CagA, a 125-140kDa protein, is injected into H. 
pylori-infected host epithelial cells where it is often activated by tyrosine phosphorylation by the 
host src kinase and targets host proteins to modify cellular responses (Hatakeyama, 2008; Peek, 
2005). Overwhelming evidence ties the presence of CagA to an increased risk of non-cardia 
gastric carcinoma over the risk caused by infection with CagA-negative H. pylori (Kamangar et 
al., 2006; Palli et al., 2007; Parsonnet et al., 1997; Sasazuki et al., 2006). The mechanisms of 
CagA pathogenicity will be discussed in more detail below. 
H. pylori has been classified as a Group I carcinogen by the International Agency for 
Research on Cancer since 1994. Numerous studies have been done to elicit the link between H. 
pylori infection and gastric cancer. A pooled reanalysis by the Helicobacter and Cancer 
Collaborative Group combined results from twelve studies and found that the matched odds ratio 
for the association of H. pylori infection and non-cardia cancer was 2.97 (95% CI: 2.34-3.77) 
(Helicobacter and Cancer Collaborative Group, 2001). Both intestinal and diffuse types of gastric 
carcinomas are associated with H. pylori infection, but only cancers found distal to the cardia 
have been linked to H. pylori infection. Besides gastric adenocarcinoma, infection with the 
bacterium has also been linked to gastric ulcers, gastritis, and MALT lymphoma. Worldwide, 
gastric cancer is the fourth most diagnosed cancer and the second most common cause of cancer-
related death, and H. pylori is the causative agent in approximately 63% of these cancers. 
Many proposed mechanisms for the pathogenicity of H. pylori exist, including changes in 
gene expression, infection-induced cell proliferation, epithelial cell elongation and loss of 
polarity, degradation of cell–cell junctions, and decreased gastric acid secretion. Recently, H. 
pylori was shown to inactivate the gastric tumor suppressor RUNX3 by two mechanisms: 
proteasome-mediated degradation (Tsang et al., 2010) induced by the H. pylori virulence factor 
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CagA, and gene silencing via promoter hypermethylation of runx3 (Kitajima et al., 2008). CagA 
is also known to bind E-cadherin, thus interfering with the normal regulation of -catenin, a 
protein whose dysregulation has been shown to cause transdifferentiation of numerous cell 
lineages and increased proliferation (Murata-Kamiya et al., 2007). Additionally, CagA inhibits 
the polarity regulator PAR1b/MARK2 kinase, which causes both loss of polarity and plays a role 
in the disruption of normal epithelial architecture (Saadat et al., 2007). CagA also binds and 
activates SHP-2 phosphatase, disrupting cell focal adhesions (Tsutsumi et al., 2006). H. pylori 
infection can also inhibit gastric acid secretion; virulence factor VacA prevents proton pump-
containing vesicles from binding to the apical membrane of parietal cells (Wang et al., 2008), 
and cagPAI genes can inhibit proton pump gene expression in parietal cells (Saha et al., 2010). 
Hypochlorhydria can lead to gastric colonization by other, more potent bacterial inducers of 
inflammation, and this increased inflammation leads to development of adenocarcinoma in mice 
(Sanduleanu et al., 2001; Zavros et al., 2002). All together, these suggest many different 
mechanisms by which H. pylori infection may lead to a host of changes in the stomach epithelia 
leading eventually to the genesis of cancer. However, one of the most important mechanisms of 
carcinogenesis is likely the induction of chronic inflammation by H. pylori. 
 
1.2 Inflammation and cancer 
Many factors are known to contribute to the development of cancer, and gastric cancer 
development is no different. Chronic infections, tobacco smoke, diet, and obesity are all major 
factors which play into the development of cancer (Aggarwal et al., 2009; Wroblewski et al., 
2010). There is a single mechanism which underlies all of these risk factors: inflammation 
(Aggarwal et al., 2009). 
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Hepatitis B or C virus infections, given their names because of their ability to cause 
chronic liver inflammation, can lead to hepatocellular carcinoma (Bouvard et al., 2009). 
Infections with many types of human papillomaviruses are recognized as key risk factors for 
cervical cancer, and the inflammation caused by persistent infection acts as a “cofactor” in 
carcinogenesis (Boccardo et al., 2010). A protein product of human T-cell 
leukemia/lymphotrophic virus type 1 (HTLV-1) “hijacks” host inflammation-regulating 
pathways to induce inflammation and transform T-cells, leading to the development of adult T-
cell leukemia (Sun and Ballard, 1999). 
There are more proposed mechanisms by which inflammation can lead to tumor initiation 
and promotion than can possibly be covered here, but a brief overview will be given. Tumor 
initiation generally requires a collection of four or more oncogenic mutations in a single cell 
which can transmit the mutations on to its progeny (Grivennikov et al., 2010). Inflammation can 
effect both increased mutation rates and upregulated cell growth. For example, inflammatory 
cytokines such as TNF-, produced in response to a wide variety of stimuli, can induce 
production of oxidant-generating enzymes in immune cells such as macrophages and neutrophils. 
These enzymes cause the accumulation of reactive oxygen and nitrogen species (ROS and RNS, 
respectively) which are meant to attack and clear the offending microbes; however, ROS/RNS 
also cause single- and double-stranded DNA breaks, point and frameshift mutations and 
chromosomal abnormalities (Ohshima et al., 2003). One of the oncogenes noted to be affected by 
ROS/RNS-induced DNA mutations is p53 (Souici et al., 2000), which represents another 
mechanism by which inflammation can increase mutation rates: dysregulation of DNA-damage 
response pathways. In addition to p53 inactivation, inflammation can also upregulate the 
expression of activation-induced cytidine deaminase (AID), an enzyme which is normally tightly 
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regulated because of its function in somatic hypermutation (Okazaki et al., 2007). AID is also 
upregulated by inflammatory cytokines, and its overexpression contributes to the development of 
lymphoma, liver and gastric cancers (Grivennikov et al., 2010). 
Inflammation can also induce stem cell-like properties in cells, increasing the chances of 
accruing the necessary mutations or allowing the growth of tumor progenitors. For example, pro-
proliferation factors such as signal transducer and activator of transcription 3 (STAT3), nuclear 
factor-B (NF-B) and -catenin are all highly activated in response to many inflammatory 
pathways. STAT3 is activated by pro-inflammatory cytokines such as IL-6 and IL-23, and it 
establishes its own feed-forward loop by transcribing more cytokines. Other targets of STAT3 
include genes involved in anti-apoptosis, pro-proliferation and the epithelial-mesenchymal 
transition (Masuda et al., 2010). STAT3 is recognized as a bona fide oncogene (Bromberg et al., 
1999), and its role in maintaining DNA-damaged stem cells has lead to the hypothesis that it may 
be instrumental in the development of cancer stem cells (Masuda et al., 2010). Constitutive NF-
B activity, often induced by chronic inflammation, has long been seen as a precursor to 
malignancy, and is found in many different types of cancers (Rayet and Gelinas, 1999). NF-B 
activation in colonic crypts can also upregulate -catenin activity, a transcription factor which 
targets genes such as cyclin D1 and c-myc to regulate proliferation. In the study by Umar et al, 
activation of this pathway leads to hyperplasia in the crypts of mice (Umar et al., 2009), and -
catenin is hypothesized to induce a “progenitor phenotype” in colon cancer cells (van de 
Wetering et al., 2002). 
 
1.3 Inflammation induced by Helicobacter pylori 
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H. pylori infection leads to inflammation through a variety of pathways, induced both in 
the gastric epithelial cells which they first contact and in circulating immune cells recruited to 
the site of infection. Inflammatory molecules found to be upregulated in the stomachs of H. 
pylori-infected patients include IL-1, IL-6, IL-8, TNF-, and RANTES, which are all regulated 
by many different pathways (Gionchetti et al., 1994; Noach et al., 1994; Shimoyama et al., 
1998). One common pathway may be through the transcription factor NF-B (Baeuerle and 
Henkel, 1994); however, much of the literature describes only the induction of one or more of 
these cytokines, particularly IL-8. 
H. pylori utilizes many different mechanisms for the induction of pro-inflammatory 
cytokines. Peptidoglycan can enter host epithelial cells via the cagPAI-encoded T4SS and 
stimulate the intracellular pathogen-recognition receptor Nod1, which in turn signals to activate 
NF-B and AP-1 for the induction of cytokines such as IL-8 (Allison et al., 2009; Viala et al., 
2004). OipA and BabA, two outer membrane adhesion proteins, were shown by knock-out 
studies to be important in the induction of IL6, IL-8 and IL-11 production, though the 
mechanism is as yet unclear (Sugimoto et al., 2011; Yamaoka et al., 2000). VacA appears to be 
primarily for immunosuppression of T cell activation, allowing persistence of the bacterial 
infection, but evidence also shows that the toxin can induce some NF-B activity within targeted 
T cells (Takeshima et al., 2009). The virulence factor CagA has been studied extensively, 
especially its role in H. pylori-induced inflammation. More introduction will be given elsewhere; 
briefly, bacteria which translocate CagA into host cells induce higher levels of IL-8 production 
(Backert et al., 2004), and activate NF-B, AP-1 and NFAT (Meyer-ter-Vehn et al., 2000; 
Naumann et al., 1999; Yokoyama et al., 2005). 
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Besides activating cytokine release, H. pylori also stimulates ROS/RNS production. H. 
pylori infection activates AP-1 to induce COX-2 and iNOS transcription, which in turn produce  
prostaglandin E2 and nitrite (Cho et al., 2010). Additionally, VacA was shown to induce ROS 
production and mitochondrial DNA mutation in gastric epithelial cells (Huang et al., 2011). H. 
pylori sonicates were observed to induce oxidative bursts from neutrophils and monocytes in 
culture (Hansen et al., 1999)via a mechanism involving the virulence factor H. pylori neutrophil-
activating protein (HP-NAP), a secreted protein which can pass through the epithelial layer into 
the lamina propria to attract leukocytes (D'Elios et al., 2007). HP-NAP induces ROS release 
from neutrophils (Evans et al., 1995) and causes the recruitment of other leukocytes to the site of 
infection by stimulating the production of chemokines such as CXCL8, CCL3 and CCL4 
(Polenghi et al., 2007). Mast cells, recruited by these chemokines, are stimulated to degranulate 
by HP-NAP, likely through a Gi protein-coupled receptor(Montemurro et al., 2002). Altogether, 
these mechanisms create an inflammatory environment conducive to the initiation and 
progression of cancer. 
 
1.4 NF-B: master regulator of inflammation 
NF-κB was discovered 25 years ago and is now one of the most extensively studied 
transcription factors. In mammals, the NF-κB/Rel family consists of seven proteins, including 
RelA/p65, c-Rel, RelB, p100, p52, p105 and p50. Each protein contains a Rel homology domain 
(RHD) within the N-terminus and can form homo- or heterodimers through the RHD (Ghosh et 
al., 1998). It is a master regulator of many cellular processes important in carcinogenesis, 
including inflammation, transformation, proliferation, angiogenesis and metastasis. Dysregulated 
NF-B is important in the pathophysiology of inflammatory diseases such as asthma, rheumatoid 
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arthritis, and systemic lupus erythematosus (Ghosh and Karin, 2002; Sethi et al., 2008). 
Additionally, NF-B is constitutively active in most human cancers, a phenotype created by 
persistent stimulation, such as through chronic infection, or via mutation leading to pathway 
activation (Chaturvedi et al., 2011).  
There are many pathways that lead to the activation of NF-κB, and many stimuli, 
including lipopolysaccharide (LPS), peptidoglycan and TNF-α(Hayden and Ghosh, 2008), which 
activate the canonical pathway, and lymphotoxin, CD40 ligand and RANK ligand, which 
primarily activate the non-canonical pathway(Sun, 2011). In the canonical pathway, the binding 
of these ligands to their receptors leads to the activation of signaling pathways which converge 
upon the phosphorylation and activation of the IκB kinase (IKK) complex, which consists of 
IKK, IKK and NEMO/IKK. This kinase complex in turn phosphorylates and induces the 
degradation of the inhibitor of κB, IκBα, which in unstimulated conditions binds and sequesters 
NF-κB within the cytoplasm. NF-κB, a heterodimer of p50 and RelA/p65, is released and moves 
into the nucleus, where it transactivates its target genes involved in inflammation, cell growth 
and survival (Chen and Greene, 2004). Posttranslational modifications, including methylation, 
acetylation and phosphorylation, are added to p65 in particular to modulate the activity of the 
transcription factor (Yang et al., 2009c), and both ubiquitination of p65 and resynthesis of IκBα 
lead to abrogation of NF-B nuclear activity(Yang et al., 2009b). In the non-canonical pathway, 
signaling from receptors activates NF-B-inducing kinase (NIK), which activates IKK. 
Together, these kinases induce proteasomal processing of p100 to the active p52, which pairs 
with RelB to form the transcriptionally active complex which activates target genes involved  in 
lymphoid organogenesis, B cell survival and maturation, and bone metabolism(Sun, 2011). 
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Due to the important role of NF-κB in inflammation-related diseases and cancer, how H. 
pylori activates NF-κB has been a long-standing question. While a number of studies have 
focused primarily on  the importance of different H. pylori virulence factors in activation of 
inflammation in general, very little is understood with regards to how H. pylori specifically 
induces the NF-B pathway. Here, I investigate the mechanisms behind H. pylori virulence 
factor-induced activation of NF-B. 
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CHAPTER 2 
HELICOBACTER PYLORI ACTIVATES NF-B IN A CagA-DEPENDENT MANNER 
 
2.1 Introduction 
H. pylori colonize the mucosal layer of the stomach, attaching themselves to the gastric 
epithelium via various bacterial adhesins and epithelial receptors (Rubinsztein-Dunlop et al., 
2005). The epithelium is therefore the first point of contact for the bacteria in the host, and the 
bacteria rarely invade any farther than the epithelial layer. Immune cells attracted to the site of 
infection by cytokines released from the epithelial cells also respond to H. pylori. This further 
amplifies the immune response from the infection and the resulting inflammation damages the 
mucosal layer, which can result in ulcers, gastritis and adenocarcinoma (Ibraghimov and Pappo, 
2000). Although H. pylori effects responses from both epithelial cells and immune cells such as 
monocytes and lymphocytes, the H. pylori-induced inflammatory response generated by gastric 
epithelial cells is the most well studied and likely the most important for understanding the 
development of gastric adenocarcinoma. 
Infection with cagPAI-positive H. pylori is associated with more severe outcomes in the 
inflammation-linked illnesses mentioned as compared to infection with cagPAI-negative H. 
pylori (Blaser et al., 1995; Kuipers et al., 1995). The approximately 40 kb cytotoxin-associated 
gene (cag) pathogenicity island contains genes which encode a type 4 secretion system (T4SS), a 
syringe-like projection which protrudes from the cell wall of the bacterium and makes contact 
with the host cell’s membrane, and a pathogenicity factor called cytotoxin-associated gene A, or 
CagA(Censini et al., 1996). A protein ranging in size from 120–145 kDa, CagA is injected into 
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the host epithelial cells via the T4SS, where it acts on a number of different signaling pathways 
leading to inflammation and cell scattering (Hatakeyama, 2004).
  
A role for CagA in the activation of NF-κB and the production of IL-8 has been 
suggested by many studies. For example, using an interleukin-8 (IL-8) promoter-reporter assay, 
Sharma et al. showed the requirement of CagA for NF-κB activation (Sharma et al., 1998). It was 
also shown that ectopically expressed CagA induced NF-κB translocation into the nucleus and 
also induced IL-8 production in gastric epithelial cells (Brandt et al., 2005; Kim et al., 2006). 
Additionally, NF-κB activation and inflammation was markedly less in the gastric antra of 
Mongolian gerbils infected with cagA-deficient H. pylori as compared to infection with wild-
type H. pylori (Shibata et al., 2006). However, the exact function of CagA in NF-κB activation is 
still unclear. Here, I demonstrate a clear dependence on the presence of CagA for NF-κB 
activation by H. pylori in gastric epithelial cells. 
 
2.2 Materials and Methods 
Cell lines, H. pylori culture and infection. Human AGS gastric adenocarcinoma and HEK293T 
cells were cultured in DMEM supplemented with 10% fetal bovine serum. H. pylori G27, 
NCTC11637 and 7.13 strains and their cagA-deficient mutants were cultured in bisulphite-free 
Brucella broth on agar media containing Ham's F-12 medium supplemented with 10% fetal 
bovine serum and 5 μg/ml vancomycin at 37°C in the presence of 10% CO2. H. pylori was added 
to AGS cells for infection at a multiplicity of infection of 50–100. All wild-type H. pylori and 
the corresponding cagA-deficient strains have similar abilities to adhere to the cells. 
Antibodies. Normal rabbit IgG, antibodies against CagA, IB, and RelA were from Santa Cruz 
Biotechnology. Phospho-S536 RelA was from Cell Signaling. 
12 
 
Immunoprecipitation, immunoblotting analysis and EMSA. Lysates from HEK293T or AGS 
cells were collected, cleared and denatured in SDS sample buffer. Lysates were separated by 
SDS-PAGE (12%), transferred to nitrocellulose transfer membranes and immunoblotted with 
various antibodies followed by visualization of the immunoreactive proteins by ECL 
(Amersham). For electrophoretic mobility-shift assay (EMSA), whole-cell extracts were 
collected from infected cells by freeze–thaw lysis. Cells were washed once with cold PBS, then 
0.5 mL cold PBS was added to each well and cells were harvested with a plastic scraper. Cells 
were collected by centrifugation, then cell pellets were lysed with whole cell extract buffer 
(20mM Hepes pH 7.0, 0.4M NaCl, 0.1% NP-40, 25% glycerol, 1mM EDTA, 2.5mM 
dithiothreitol, and 1mM phenylmethylsulfonyl fluoride). Cell pellets were mixed by pipetting 
and incubated on ice for 30 min, then vortexed for 30 s. Lysates were frozen in liquid nitrogen, 
thawed on ice, and vortexed for 1 min before centrifuging to collect supernatants. NF-κB DNA-
binding activity was assessed in electrophoretic mobility shift assays (EMSA) with a 
32
P-
radiolabeled consensus κB enhancer oligonucleotide (5′-AGTTGAGGGGACTTTCCCAGGC-
3′) incubated with 6g whole cell extract at 30˚C for 15 min. For supershift assay, 2L of either 
anti-RelA (SC-109, Santa Cruz Biotechnology, Santa Cruz, CA) or anti-p50 (SC-1190, Santa 
Cruz) was added to the mixture. Comparability of the various nuclear extracts was assessed by 
EMSA with a 
32
P-radiolabeled Oct1 probe (Promega). 
Quantitative real-time PCR analysis. AGS cells were infected with H. pylori for various times 
and total RNA was extracted using the RNeasy Mini kit (Qiagen, Valencia, CA, USA). 
Complementary DNA was synthesized using the Omniscript RT kit (Qiagen). Quantitative real-
time PCR was performed using the Qiagen SYBR green PCR kit, with the aid of the 7300 Real-
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time PCR system (ABI, Foster City, CA, USA). PCR primers for human β-actin, IL-8 and TNF-
α were purchased from Qiagen. 
Transient transfection, plasmids and luciferase reporter assay. CagA-HA and mutants have 
been described (Lu et al., 2008), and were a gift from Dr. M. Hatakeyama. For experiments using 
HEK293T cells, transfection was performed using the calcium phosphate method. For 
experiments using AGS cells, either calcium phosphate or Lipofectamine 2000 was used to 
transfect cells (Invitrogen). For luciferase assay, cells were infected with H. pylori 24 hours post-
transfection, and then lysed in passive lysis buffer; firefly and renilla luciferase activities were 
measured with the dual luciferase assay system from Promega. Firefly luciferase activity was 
normalized to renilla luciferase activity. Results represent the average of three independent 
experiments ± s.d. 
 
2.3 Results 
To investigate the role of CagA in the H. pylori-induced inflammatory response, we 
compared wild-type and cagA-deficient H. pylori for their ability to induce the expression of 
inflammatory genes in AGS gastric epithelial cells. Infection of AGS cells with wild-type H. 
pylori strain G27, but not its cagA-deficient isogenic mutant, induced the expression of IL-8 and 
TNF- messenger RNA (mRNA; Fig 2.1). Similar results were obtained with two other H. pylori 
strains: NCTC11637 and 7.13 (Fig 2.2). These data indicate that induction of proinflammatory 
genes can be generalized for most cagA-positive H. pylori strains. Further, since multiple strains 
and their derived mutants give similar results, the defect from the cagA-deficient mutants is 
unlikely to be due to a polar effect.  
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Figure 2.1. CagA is required for activation of NF-B. AGS 
cells were infected with wild-type or cagA-deficient H. pylori 
for indicated timepoints, genes involved in the inflmmatory 
response were measured. 
Figure 2.2. CagA is required for activation of NF-B. AGS cells 
were infected with wild-type or cagA-deficient strains of H. 
pylori for indicated timepoints, TNF- mRNA was measured. 
 
As NF-B regulates the expression of many inflammatory cytokines, including IL-8 and 
TNF-, we next investigated whether H. pylori infection activated NF-B and whether this 
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Figure 2.3.  H. pylori activates NF-κB in a cagA-dependent manner. 5XκB-
luciferase (5XκB-Luc), IL-8-luciferase (IL-8-luc) or E-selectin-luciferase (E-
selectin-luc) reporter plasmids were transfected into AGS cells followed by 
infection with H. pylori. Luciferase activity was measured 6 h after infection. 
Figure 2.4. H. pylori stimulates binding of NF-B to DNA. A EMSA was performed using 
whole-cell extracts from AGS cells infected with wt or CagA H. pylori by using 
radiolabelled NF-B and Oct1 probes. B Super-shift assay using anti-RelA or anti-p50 
antibodies was performed using WT 60 min timepoint sample from Fig 2.4A. Super-shifts are 
indicated by arrows.  
activation was CagA-dependent. Wild-type G27 H. pylori, but not its cagA-deficient mutant, 
activated all three B luciferase reporters, including two that contain natural promoters from NF-
B target genes IL-8 and E-selectin (Fig. 2.3). Furthermore, only wild-type H. pylori, but not the 
cagA-deficient mutant, stimulated the binding of NF-B, a heterodimer of RelA and p50, to 
DNA, showing that CagA specifically activates the canonical NF-B pathway (Fig. 2.4).  
Phosphorylation and multimerization are two properties of CagA that are essential for 
many of its functions within host epithelial cells, including the ability to deregulate the SHP-2 
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phosphatase to induce the “hummingbird” phenotype  and the ability to bind the PAR1 kinase to 
inhibit cell-cell junction stability, respectively (Hatakeyama, 2008). To determine whether either  
of these modifications are necessary for CagA activation of NF-B, wild-type, phosphorylation-
deficient (PR), single EPIYA and multimerization domain-containing (ABCC), or 
multimerization-deficient (ABCC-16AA) CagA were ectopically expressed along with 
luciferase reporter and Renilla control plasmids in HEK293T cells. Though expression of CagA 
was low, NF-B activity did increase over basal activity, indicating that CagA alone was 
sufficient for NF-B activation (Fig. 2.5). Further, while neither the phosphorylation-deficient 
mutant nor the single EPIYA and multimerization domain-containing mutant showed a changed 
ability to activate NF-B, multimerization-deficient CagA was not able to activate NF-B (Fig. 
Figure 2.5. Oligomerization, but not phosphorylation, is required for 
activation of NF-B by CagA. 293T cells were transfected with IL-8-
luciferase, Renilla, and wild-type and various CagA-deletion mutants. 30 
hours post-tranfection, cells were harvested and lysates were assayed for 
luciferase activity. 
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Figure 2.6.  H. pylori activates NF-B through the canonical pathway. 
Levels of IB, phosphorylated Ser 536 RelA, RelA, CagA and tubulin 
were detected in lysates from AGS cells infected with G27 wt or CagA H. 
pylori by immunoblotting with the indicated antibodies. 
2.5). These data show that while phosphorylation of CagA is dispensible for NF-B activation, 
multimerization is not.  
To define the signaling pathway leading to the activation of NF-B, we examined the 
degradation and re-synthesis of IB and phosphorylation of RelA in AGS cells infected with 
wild-type and cagA-deficient H. pylori. IB was degraded and resynthesized in cells infected 
with wild-type but not in those infected with cagA-deficient H. pylori (Fig. 2.6). In addition, 
wild-type H. pylori, but not the cagA-deficient mutant, stimulated the phosphorylation of RelA at 
Ser 536, which is also mediated by activated IKK (Fig. 2.6). All together, these data indicate that 
H. pylori infection stimulates CagA-dependent activation of NF-B through the activation of 
IKK. 
 
2.4 Discussion 
Despite the essential role of the cagPAI in the activation of NF-κB and the induction of 
IL-8 in epithelial cells, the requirement for CagA, not just the T4SS, for the inflammatory 
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response has been a point of contention nearly since the discovery of the pathogenicity island. It 
has been reported that the T4SS, but not CagA, is required for H. pylori-mediated production of 
IL-8 since T4SS mutants failed to induce IL-8 (Naumann, 2005). However, as the T4SS 
translocates CagA into host cells, impaired NF-κB activation by mutants in which the T4SS is 
defective cannot rule out the possibility that the important component is, in fact, CagA. Another 
concern regarding the requirement of CagA for H. pylori-mediated NF-κB activation is the 
potential for polar effects from the deletion of the cagA gene, in which disruption of one gene 
causes disruption of genes downstream within the same operon (Fischer et al., 2001). 
Nevertheless, as cagA is monocistronic and transcribed in a different direction than other genes 
comprising the cagPAI (Censini et al., 1996), it is unlikely that the H. pylori isogenic cagA 
mutant strains are exerting polar effects on other genes within the cagPAI. Concordantly, no 
polar effects have been reported for the cagA-deficient H. pylori strains in the literature. 
While CagA has clearly been shown to be essential for the activation of NF-κB, it must 
be noted that this requirement could be H. pylori strain-specific. The considerable variation in 
the sequences of CagA from different H. pylori strains led to the designation of “Western” and 
“Eastern” strains based on the sequences surrounding the phosphorylation domains in the C 
terminus of the protein. These differences correlate with the ability of the CagA protein to 
associate with SHP-2 and induce the “hummingbird” phenotype (Higashi et al., 2002). Sequence 
variations within the CagA multimerization domain influence cell-cell junctions and cell polarity 
along with association with SHP-2 (Lu et al., 2008). In addition to affecting cell and epithelial 
morphologies, strain variations have also been linked to variations in IL-8 production. 
Exchanging cagA genes allows low IL-8-inducing H. pylori strains to be converted into high 
inducing strains and vice versa (Brandt et al., 2005). We hypothesize that these effects may be 
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caused by increased or decreased abilities of these CagA proteins to bind and activate upstream 
signaling components, such as TAK1, influencing the downstream activity of NF-κB. However, 
the sequences required for CagA to induce NF-κB activation remain elusive and need further 
investigation. 
Additionally, the requirement for CagA in the activation of NF-κB could also be cell-type 
specific. CagA seems to not be essential for H. pylori-induced activation of NF-κB in cells other 
than gastric epithelial cells. In macrophages, H. pylori activates NF-κB via TLR2 (for induction 
of IL-6 and IL-1β) and TLR4 (for induction of IL-12, IL-10 and IL-8) (Maeda et al., 2001; 
Obonyo et al., 2007). Findings similar to those of the activation in macrophages were reported in 
lymphocytes by Ohmae et al. In human B lymphocytes, H. pylori activates not only the NF-κB 
classical pathway, but also the non-canonical pathway, which involves the processing of p100, 
reportedly by TLR4 recognition of H. pylori LPS (Ohmae et al., 2005). 
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CHAPTER 3 
TAK1 UBIQUITINATION AND ACTIVATION IS ENHANCED BY HELICOBACTER 
PYLORI CagA 
 
3.1 Introduction 
Many pathways activate NF-B, including both the classical and non-classical pathways, 
and there are a great number of signaling molecules involved in all of the pathways. How CagA 
is able to activate the canonical NF-B pathway is an important question for the understanding 
of H. pylori-induced inflammation, as well as for understanding the mechanisms which 
pathogens may use to dysregulate a system. One critical signal transducer which has recently 
been found to be targeted by virulence factors of other pathogens, such as human T-
lymphotrophic virus-1 protein TAX and herpes simplex virus-1 ICP0 (Wu and Sun, 2007, Diao 
et al., 2005), is transforming growth factor- (TGF-)-activated kinase 1 (TAK1). 
TAK1, a mitogen-activated protein kinase kinase kinase (MAPKKK) family member 
which phosphorylates serine/threonine, was initially found to be activated by TGF-and bone 
morphogenetic protein (Yamaguchi et al., 1995). Besides members of the TGF-family, TAK1 
can also be activated in response to IL-1, TNF-, and Toll-like receptor ligands. Its targets 
include MKK3/6, IKK, AMP-activated protein kinase, LKB1, and p38 (Wang et al., 2001; 
Witczak et al., 2008; Xie et al., 2006; Yamaguchi et al., 1995), which can regulate transcription 
factors such as AP-1, NF-B and p53 (Oeckinghaus et al., 2011; Yaswen and Campisi, 2007). 
The myriad targets of TAK1 give it a pivotal role in the regulation of immunity, inflammation, 
differentiation and growth, and cell survival. 
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Though the activation of IKK by TAK1 is not clearly understood, emerging evidence 
indicates that it is regulated by tumor necrosis factor receptor-associated factor 6 (TRAF6)-
mediated, lysine 63 (K63)-linked ubiquitination of TRAF6, TAB2/3, and NF-B essential 
modulator (NEMO; Adhikari et al., 2007). Ubiquitin is a small protein which can be catalytically 
added to lysines of targeted proteins by being activated by one of two E1s, transferred to one of 
around thirty different E2s, and then added to the target selectively by one of many hundred E3 
ligases. One or a progressively linked chain of ubiquitin molecules, linked from one of seven 
internal lysines to the C-terminus of the next molecule, may be added to a target. K48-linked and 
K63-linked ubiquitin chains are the two most prevalent types of linkages; K48-linked 
ubiquitination functions to signal proteasomal degradation, while K63-linked ubiquitination 
functions as a scaffold to bring together proteins in a signaling pathway (Chen, 2005)(Chen and 
Greene, 2005; Chen, 2005).  
TAB2/3 interact with TAK1 constitutively, and their interaction with K63-linked 
polyubiquitin chains is required for the activation of TAK1 (Kanayama et al., 2004). NEMO 
ubiquitination is not well understood, though it appears to be required for NF-B activity in 
response to TLR activation (Ni et al., 2008); additionally, NEMO has ubiquitin binding domains 
which may be required for interacting with the TAK1 complex (Ea et al., 2006). Recent studies 
also show that TAK1 is polyubiquitinated by TRAF6 in response to TGF-, and that K63-linked 
ubiquitination is required for TGF--induced activation of p38/JNK and AP-1 (Sorrentino et al., 
2008), indicating that TAK1 ubiquitination might also be crucial for the activation of IKK and 
NF-B. 
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Many of CagA’s targets are found near the membrane, like many receptors and receptor-
bound intermediates which can trigger TAK1 activation. The interaction of CagA with one 
membrane protein, the hepatocyte growth factor receptor Met, leads to the activation of another 
important kinase, Akt (Suzuki et al., 2009). Combined with the evidence that cagA-positive H. 
pylori activates the IKK complex, we were thus interested in determining whether H. pylori 
CagA might cause the activation of TAK1. 
 
3.2 Materials and Methods 
Cell lines, H. pylori culture and infection. Human AGS gastric adenocarcinoma, HEK293T and 
MEF cells were cultured in DMEM supplemented with 10% fetal bovine serum. H. pylori G27  
was cultured in bisulphite-free Brucella broth on agar media containing Ham's F-12 medium 
supplemented with 10% fetal bovine serum and 5 μg/ml vancomycin at 37°C in the presence of 
10% CO2. H. pylori was added to AGS or MEF cells for infection at a multiplicity of infection of 
50–100. 
Plasmids. CagA was amplified by PCR from the genomic DNA of H. pylori strain G27 and 
subcloned into the pcDNA3.1-Flag or pcDNA3.1-T7 vector. HA-TAK1 was received as a gift 
from Dr. J. Ninomiya-Tsuji and Flag-TAK1 was received as a gift from Dr. X. Lin. His-MKK6 
(K82A) was received as a gift from Dr. Z. J. Chen. 
Antibodies. Normal rabbit IgG, antibodies against CagA, TAK1, IKK1, IB, RelA, Flag, HA, 
His and ubiquitin were from Santa Cruz Bio. Anti-T7 antibody was from Covance. Phospho-
S536 RelA, phospho-IB (S32/26) and phospho-TAK1 (T187) were from Cell Signaling. 
TAK1 siRNA knockdown and rescue. TAK1 siRNA from Ambion was transfected into AGS 
cells using Lipofectamine 2000 according to the manufacturer’s protocol. 36 hrs post-
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transfection, cells were split, and 36 hr later were infected with H. pylori. For rescue, cells were 
transfected with 40ng Flag-TAK1 per well of a 12-well plate using Lipofectamine 2000 24 hrs 
before infection.  
Immunoprecipitation, immunoblotting analysis and EMSA. Immunoprecipitation, 
immunoblotting analysis and EMSA. Lysates were immunoprecipitated for 2 hours at 4°C 
using 20 L of a slurry containing 50% anti-T7-conjugated or anti-Flag-conjugated agarose 
beads (Novagen or Sigma), or with 5 L of various antibodies and 20 L Protein A agarose 
beads (Sigma). These immunoprecipitates were washed three times in lysis buffer. Lysates from 
HEK293T or AGS cells were collected, cleared and denatured in SDS sample buffer. Lysates or 
immunoprecipitates were separated by SDS-PAGE (10-13%), transferred to nitrocellulose 
transfer membranes and immunoblotted with various antibodies followed by visualization of the 
immunoreactive proteins by ECL (Amersham). For electrophoretic mobility-shift assay (EMSA), 
whole-cell extracts were collected from infected cells by freeze–thaw lysis. Cells were washed 
once with cold PBS, then 0.5 mL cold PBS was added to each well and cells were harvested with 
a plastic scraper. Cells were collected by centrifugation, then cell pellets were lysed with whole 
cell extract buffer (20mM Hepes pH 7.0, 0.4M NaCl, 0.1% NP-40, 25% glycerol, 1mM EDTA, 
2.5mM dithiothreitol, and 1mM phenylmethylsulfonyl fluoride). Cell pellets were mixed by 
pipetting and incubated on ice for 30 min, then vortexed for 30 s. Lysates were frozen in liquid 
nitrogen, thawed on ice, and vortexed for 1 min before centrifuging to collect supernatants. NF-
κB DNA-binding activity was assessed in electrophoretic mobility shift assays (EMSA) with a 
32
P-radiolabeled consensus κB enhancer oligonucleotide (5′-
AGTTGAGGGGACTTTCCCAGGC-3′) incubated with 6g whole cell extract at 30˚C for 15 
min. For supershift assay, 2L of either anti-RelA (SC-109, Santa Cruz Biotechnology, Santa 
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Cruz, CA) or anti-p50 (SC-1190, Santa Cruz) was added to the mixture. Comparability of the 
various nuclear extracts was assessed by EMSA with a 
32
P-radiolabeled Oct1 probe (Promega). 
Quantitative real-time PCR analysis. AGS or MEF cell lines were infected with H. pylori for 
various times and total RNA was extracted using the RNeasy Mini kit (Qiagen, Valencia, CA, 
USA). Complementary DNA was synthesized using the Omniscript RT kit (Qiagen). 
Quantitative real-time PCR was performed using the Qiagen SYBR green PCR kit, with the aid 
of the 7300 Real-time PCR system (ABI, Foster City, CA, USA). PCR primers for human β-
actin, IL-8 and TNF-α, as well as mouse β-actin, E-selectin, IL-6 and TNF-α, were purchased 
from Qiagen. 
Transient transfection and luciferase reporter assay. For experiments using HEK293T cells, 
transfection was performed using the calcium phosphate method. For experiments using AGS 
cells, either calcium phosphate or Lipofectamine 2000 was used to transfect cells (Invitrogen). 
For luciferase assay, cells were lysed in passive lysis buffer 30 hours post-transfection; firefly 
and renilla luciferase activities were measured with the dual luciferase assay system from 
Promega. Firefly luciferase activity was normalized to renilla luciferase activity. Results 
represent the average of three independent experiments ± s.d. 
 
3.3 Results 
To better understand the way in which H. pylori-induces activation of IKK and NF-B, 
we investigated the role of TAK1. To do so, we first utilized mouse embryonic fibroblasts 
(MEFs) from paired wild-type and TAK1-deficient (TAK1-/-) mice. When these MEFs were  
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Figure 3.1. H. pylori activation of NF-B requires TAK1.  A Levels of IB, phosphorylated 
Ser 536 RelA, RelA, TAK1 and tubulin were detected in the lysates from wt or TAK1-/- 
MEFs infected with H. pylori. B EMSA was performed using whole-cell extracts from wt or 
TAK1-/- MEFs infected with H. pylori, as in Fig 3.1A. 
Figure 3.2. TAK1 is required for activation of NF-κB by H. pylori in MEFs. WT and TAK1-
/- MEFs were uninfected or infected for 8 hrs with H. pylori. Quantitative RT-PCR was 
performed to analyze the H. pylori-induced expression of NF-κB target genes. 
infected with H. pylori, NF-B activation was induced in wild-type MEFs but not in TAK1-/- 
MEFs, as seen by evaluating IB degradation and resynthesis and phosphorylation of Ser 536 
of RelA (Fig 3.1A). Furthermore, H. pylori stimulated the DNA-binding activity of NF-B in 
wild-type but not in TAK1-/- MEFs (Fig 3.1B). These data indicate that TAK1 is essential for 
the activation of IKK and NF-B after H. pylori infection. Consistently, infection of wild-type 
MEFs, but not TAK1-/- MEFs, with H. pylori stimulated mRNA expression of TNF-, IL-6 and 
E-selectin—three NF-B target genes (Fig. 3.2). 
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Figure 3.3. TAK1 is required for activation of NF-B by H. pylori in gastric epithelial cells. 
A AGS cells transfected with control or TAK1 siRNA were infected with H. pylori and RT–
PCR was performed to analyze NF-B target gene expression. Levels of TAK1 and tubulin 
are shown in the right panels. B AGS cells transfected with control siRNA or TAK1 siRNA 
were reconstituted with mouse TAK1 (mTAK1), followed by infection for 4 h with H. pylori. 
Gene expression was analysed as shown in Fig. 3.3A. 
 
Since MEF cells may not accurately represent the gastric epithelium’s response to H. 
pylori, we sought to determine whether TAK1 might play a role in H. pylori-induced NF-B 
activation in a more physiologically-relevant model. We therefore used short interfering RNA 
(siRNA) to knock down the expression of TAK1 in AGS cells. Depletion of TAK1 by siRNA 
impaired the H. pylori-induced mRNA expression of TNF- and IL-8 (Fig 3.3A). The partial 
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Figure 3.4. H. pylori infection causes ubiquitiniation of TAK1. 
AGS cells were infected with wild-type or cagA H. pylori, 
TAK1 was immunoprecipitated and immunoblotted for ubiquitin. 
decrease in expression of TNF- and IL-8 mRNA in TAK1-knockdown cells (compared with 
TAK1-/- MEFs) probably reflects the incomplete depletion of TAK1 by siRNA in AGS cells 
(with approximately 80% knockdown efficiency; Fig 3.3A). To confirm that the impaired 
activation of NF-B-driven transcription was indeed a result of depletion of TAK1 rather than a  
secondary effect from the siRNA, siRNA-resistant mouse TAK1 was reintroduced into the 
knockdown cells (Fig. 3.3B). The impaired expression of TNF- and IL-8 was “rescued” by 
reintroduction of TAK1. These data confirm that TAK1 is essential for H. pylori-induced 
activation of NF-B.  
As K63-linked polyubiquitination is important for the activation of TAK1 and IKK 
(Sorrentino et al., 2008; Wang et al., 2001), and TAK1 is essential for H. pylori-induced 
activation of NF-B (Figs. 3.1-3.3), we next examined whether H. pylori stimulated 
polyubiquitination of TAK1. Infection of AGS cells with wild-type, but not cagA-deficient, H. 
pylori induced polyubiquitination of endogenous TAK1 (Fig. 3.4), indicating that CagA is 
crucial for H. pylori-induced polyubiquitination of TAK1. Next, we determined the potential 
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Figure 3.5. CagA enhances TAK1 ubiquitination. A Flag-TAK1 from HEK293T cells 
transfected as indicated was immunoprecipitated and immunoblotted for ubiquitination using 
HA antibodies. B Lysates from HEK293T cells transfected similarly to those in Fig. 3.5A 
were denatured before Flag-TAK1 was immunoprecipitated and immunoblotted for 
ubiquitination. C HEK293T cells were transfected with Flag-TAK1 with or without T7-CagA 
and with wt, Lys 48-only or Lys 63-only HA–ubiquitin as indicated. TAK1 ubiquitination was 
detected by immunoblotting Flag immunoprecipitates with HA antibodies. 
effect of CagA on the ubiquitination of TAK1. TAK1 is modestly ubiquitinated in the presence 
of ubiquitin, and this ubiquitination is markedly enhanced by co-transfection of CagA (Fig. 
3.5A). To ensure that the ubiquitination observed was directly bound to TAK1 and not a co-
immunoprecipitated partner, the ubiquitination experiment was repeated using denaturing 
conditions designed to separate TAK1 from any non-covalently bound partners prior to 
immunoprecipitation. Similar results were obtained under these conditions, indicating that while 
 other partner proteins of TAK1 are also known to be ubiquitinated, TAK1 itself is ubiquitinated  
in response to CagA (Fig. 3.5B). Further, the enhanced ubiquitination of TAK1 is Lys 63-linked  
rather than Lys 48-linked, as enhanced ubiquitination of TAK1 could only be detected in the 
presence of wild-type or Lys 63-only ubiquitin, but not in the presence of Lys 48-only ubiquitin 
(Fig. 3.5C), indicating that ubiquitination of TAK1 enhanced by CagA probably promotes the 
activity of TAK1 rather than its proteasomal degradation.  
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As CagA enhances the ubiquitination of TAK1 (Fig. 3.5), we next examined whether 
CagA could stimulate TAK1 kinase activity. One of the markers of TAK1 kinase activity is 
autophosphorylation of TAK1; threonines 178, 184, and 187 and serine 192 may be 
phosphorylated after activation by various stimulants (Singhirunnusorn et al., 2005; Yu et al., 
2008). To evaluate kinase activation of TAK1 by CagA, CagA and TAK1 were co-expressed in 
293T cells, and lysates were immunoblotted for phosphorylated TAK1 at T187; kinase activity 
Figure 3.6. CagA enhances TAK1 activity. A 293T cells were transfected as 
indicated. Anti-Flag immunoprecipitates were separated by SDS-PAGE and 
immunoblotted for phosphorylated TAK1. B AGS cells were infected with wild-
type or dCagA H. pylori; immunoprecipitates of TAK1 or IKK were assayed for 
kinase activity. C 293T cells were transfected with TAK1 and increasing amounts 
of CagA along with IL-8 promoter-driven luciferase. 36 hrs post-tranfection, 
luciferase activity was assayed and normalized to Renilla. 
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of TAK1 was enhanced by CagA (Fig. 3.6A). H. pylori infection in AGS cells also activated 
TAK1 and IKK with similar kinetics in a CagA-dependent manner, as observed in TAK1 and 
IKK kinase assays performed with immunoprecipitates from infected cells (Fig. 3.6B). 
Consistently, TAK1-mediated activation of NF-B was enhanced by CagA in a dose-dependent 
manner in a B-luciferase reporter assay (Fig. 3.6C). 
CagA is localized to the plasma membrane and undergoes multimerization—two events 
that are essential for its signal transduction activity (Hatakeyama, 2008). Staining for 
overexpressed CagA and TAK1 showed that CagA colocalizes with TAK1 on the plasma 
membrane. While phosphorylation-deficient CagA induced ubiquitination to the same level as 
wild-type CagA, the multimerization-defective mutant of CagA failed to induce the 
ubiquitination of TAK1, a result which mirrors that observed in the mutants’ abilities to activate 
Figure 3.7. Ubiquitination of lysine 158 of TAK1 is enhanced by CagA. A & B Wild type and 
TAK1 lysine-to-arginine mutants were expressed in 293T cells along with ubiquitin and 
CagA. Anti-Flag precipitates were immunoblotted for HA. 
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NF-B (Fig. 3.6). It appears that the membrane-binding and oligomerization properties of CagA 
are likely important for the activation of TAK1 and NF-B. 
While it is apparent that CagA enhances the ubiquitination of TAK1, the importance of 
this ubiquitination is not completely clear. To better understand the role of ubiquitination of 
TAK1 in activation of the kinase and the NF-B pathway, we looked for the specific lysine(s) 
being ubiquitinated in the presence of CagA. Various lysines have been reported as sites for 
ubiquitination in response to different stimuli, including TNF- and IL-1-induced K158 
Figure 3.8. Ubiquitination at K158 of TAK1 is important for its activation by H. pylori 
CagA. A WT or K158R TAK1 were expressed in 293T cells along with IL-8-luciferase and 
Renilla with increasing amounts of CagA. Luciferase activity was assayed as in 3.6C. B WT 
or K158R TAK1 were expressed in 293T cells with or without CagA. Flag-TAK1 
immunoprecipitates were immunoblotted for phosphorylated TAK1. C AGS cells expressing 
WT or K158R TAK1 were infected with H. pylori for indicated times. Flag-TAK1 
immunoprecipitates were immunoblotted for phosphorylated TAK1. 
32 
 
ubiquitination and TGF--induced K34 ubiquitination (Fan et al., 2010; Sorrentino et al., 2008). 
Additionally, we found a potential site at K573 by mass spectrometry. To examine these sites, 
we created lysine-to-arginine mutants of each and overexpressed them in 293T cells along with 
ubiquitin and CagA. Mutation of K34 or K573 did not cause any reduction in either basal 
ubiquitination or in ubiquitination enhanced by CagA as compared to the wild-type (Fig 3.7). 
However, mutation of K158 resulted in considerably less basal ubiquitination, and no enhanced 
ubiquitination was observed with the addition of CagA. Ubiquitination of overexpressed K158R 
TAK1 after H. pylori infection in AGS cells was also significantly lower than that of 
overexpressed wild-type TAK1. 
Having identified the lysine to which ubiquitin is added in response to H. pylori infection, 
we next went on to characterize the role which ubiquitination plays in H. pylori-induced TAK1 
and NF-B activation. In a luciferase reporter assay, IL-8-promoter luciferase was only induced 
by wild-type TAK1, and increased luciferase activity was only seen upon the addition of CagA 
to wild-type TAK1, not K158R mutant TAK1 (Fig. 3.8A).  
Next, we looked at the kinase activity of TAK1. Autophosphorylation of wild-type TAK1 
was increased when overexpressed along with CagA, but no basal or enhanced 
autophosphorylation of K158R TAK1 was observed (Fig. 3.8B). A similar result was seen when 
autophosphorylation of wild-type or K158R TAK1 was examined after H. pylori infection (Fig. 
3.8C). All together, these data indicate that CagA enhances the ubiquitination of TAK1 at K158, 
a modification which is required for the H. pylori-induced activation of NF-B. 
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3.4 Discussion 
TAK1 is targeted by a number of different virulence factors from different pathogens, 
some to enhance and some to suppress NF-B activity. Why TAK1 would be the target of choice 
for such a variety of pathogens is an interesting question, and one about which we may currently 
only hypothesize. TAK1 activates the IKK complex, a complex critical for the full activation of 
NF-B. It may be that TAK1 is targeted by many microbial species because it plays such a 
crucial role in regulation of inflammation that circumventing the role of TAK1 is not an option 
for the host. 
Finding that a key feature in the H. pylori activation of TAK1 is its ubiquitination at 
lysine 158 is a novel mechanism for pathogen interference in a host pathway. However, the role 
of K63-linked ubiquitination of TAK1 in its activation is not well understood. The E3 ligase just 
upstream of TAK1, TRAF6, ubiquitinates itself, and the zinc fingers in TAK1-binding proteins 2 
and 3 (TAB2/3) specifically recognize the K63-linked chains and recruit the TAK1 complex to 
TRAF6 to be activated (Kanayama et al., 2004). Perhaps TAK1 ubiquitination is involved in a 
conformational change at that point, or perhaps TAK1 ubiquitination allows recruitment of other 
TAK1 complexes which in close proximity can promote cross-phosphorylation, resulting in 
active kinases. Other proteins in the pathway bind ubiquitin chains, such as NEMO, and 
ubiquitin binding by NEMO is required for activation of the IKK complex (Windheim et al., 
2008).  
A recent study challenges the idea that the ubiquitin chain must be anchored to a target 
protein to act. In their study, Xia et al find that free K63-linked ubiquitin chains, not attached to 
any other proteins, can bind the ubiquitin-binding domain of TAB2 and activate the TAK1 
complex in vitro (Xia et al., 2009). Another study found that a TRAF6 mutant with no lysines 
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was competent at activating TAK1 and the NF-B pathway in rescued TRAF6-deficient mouse 
embryonic fibroblasts, indicating that while the E3 ligase was required for activation of TAK1, 
ubiquitin chains attached to TRAF6 were not (Walsh et al., 2008). However, the free ubiquitin 
data was collected in vitro only, and would be difficult to determine in vivo. Also, two 
deubiquitinases, A20 and CYLD, have been found to be important for deubiquitinating targets 
such as RIP1 and TAK1 within the NF-B pathway (Harhaj and Dixit, 2011). Such enzymes 
would seem irrelevant if ubiquitination of these proteins was not, in fact, required for some 
function within the pathway. 
Lysine 158 in TAK1 appears to play a very important role in activation of the kinase and 
NF-B. We found that ubiquitination of TAK1 when this lysine was mutated to arginine was 
sharply decreased, even when co-expressed with ubiquitin alone. The kinase activity and 
autophosphorylation of TAK1 K158R was also much less than the wild-type TAK1. Besides 
being a critical site of ubiquitination, the mutation of this lysine may also change the 
conformation of TAK1 in such a way as to make it a dead enzyme. Further studies, potentially 
involving protein crystallography, would be helpful to better define the role of this lysine. 
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CHAPTER 4 
TAK1 UBIQUITINATION IN RESPONSE TO HELICOBACTER PYLORI REQUIRES 
E2 UBC13 AND E3 TRAF6 
 
4.1 Introduction 
Like many other modifications, ubiquitination is a modification which required enzymes 
to specifically recognize and attach a molecule to a target protein. In the process, illustrated in 
Figure 4.1, one of the two known E1 enzymes uses ATP to form a thioester bond between a 
cysteine within the E1 and the C-terminus of ubiquitin, a small, 76-amino acid protein.  Next, 
ubiquitin is transferred to an ubiquitin-conjugating enzyme, E2, which also binds ubiquitin 
through a thioester bond. Finally, an E3 ligase specifically guides the ubiquitin to covalently 
attach to a target protein via an isopeptide bond between the carboxy terminus of ubiquitin and -
amino group of a lysine on the target. A single ubiquitin molecule may be added to a target 
Figure 4.1. Schematic of ubiquitination catalysis. 
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protein, or a chain of ubiquitins may be added, attached processively from one of seven internal 
lysines within ubiquitin to the C-terminus of the next ubiquitin. More than forty E2s and 
hundreds of E3s are found in mammalian genomes. Ubiquitin conjugating E2s are thought to be 
responsible for the types of ubiquitin-ubiquitin linkages which are constructed in ubiquitin 
chains, and E3 ligases direct the ubiquitination of specifically recognized targets. 
To better understand the pathway utilized for H. pylori-induced TAK1 ubiquitination and 
activation, we sought to determine the ubiquitin conjugating E2 and the E3 ligase required for 
TAK1 ubiquitination, and the requirement for each in the activation of NF-B by H. pylori 
infection. 
 
4.2 Materials and Methods 
Cell lines, H. pylori culture and infection. Human AGS gastric adenocarcinoma and HEK293T 
cells were cultured in DMEM supplemented with 10% fetal bovine serum. H. pylori G27 was 
cultured in bisulphite-free Brucella broth on agar media containing Ham's F-12 medium 
supplemented with 10% fetal bovine serum and 5 μg/ml vancomycin at 37°C in the presence of 
10% CO2. H. pylori was added to AGS cells for infection at a multiplicity of infection of 50–100. 
Plasmids. CagA was amplified by PCR from the genomic DNA of H. pylori strain G27 and 
subcloned into the pcDNA3.1-Flag or pcDNA3.1-T7 vector. TRAF6 was subcloned into the 
pcDNA3.1-T7 vector. HA-TAK1 was received as a gift from Dr. J. Ninomiya-Tsuji and Flag-
TAK1 was received as a gift from Dr. X. Lin. His-MKK6 (K82A) was received as a gift from 
Dr. Z. J. Chen. 
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Antibodies. Normal rabbit IgG, antibodies against CagA, TAK1, TRAF6, Flag, HA, His and 
ubiquitin were from Santa Cruz Biotechnology. Anti-T7 antibody was from Covance. Phospho-
S536 RelA, phospho-IB (S32/36) and phospho-TAK1 (T184/187) were from Cell Signaling. 
siRNA knock down. Ubc13, Uev1a, and UbcH7 siRNA from Ambion (Ubc13-A sense: 
CCAGAUGAUCCAUUAGCAAtt; Ubc13-B sense: GCAUGGACUAGGCUAUAUUtt; Uev1a 
sense: ACUUACAAGAUGGACAGGGtt; UbcH7 sense: AUGUGGGAUGAAAAACUUCtt) 
was transfected into AGS cells using Lipofectamine 2000 according to the manufacturer’s 
protocol. 24 hours post-transfection, cells were transfected with Flag-TAK1, HA-TAK1, HA-Ub, 
and/or T7-CagA as described, and 24 hours later cells were infected or harvested for further 
experiments. 
Immunoprecipitation, immunoblotting analysis and EMSA. Lysates were 
immunoprecipitated for 2 hours at 4°C using 20 L of a slurry containing 50% anti-T7-
conjugated or anti-Flag-conjugated agarose beads (Novagen or Sigma), or with 5 L of various 
antibodies and 20 L Protein A agarose beads (Sigma). These immunoprecipitates were washed 
three times in lysis buffer. Lysates from HEK293T or AGS cells were collected, cleared and 
denatured in SDS sample buffer. Lysates or immunoprecipitates were separated by SDS-PAGE 
(10-13%), transferred to nitrocellulose transfer membranes and immunoblotted with various 
antibodies followed by visualization of the immunoreactive proteins by ECL (Amersham). 
Quantitative real-time PCR analysis. AGS cells were infected with H. pylori for various times 
and total RNA was extracted using the RNeasy Mini kit (Qiagen, Valencia, CA, USA). 
Complementary DNA was synthesized using the Omniscript RT kit (Qiagen). Quantitative real-
time PCR was performed using the Qiagen SYBR green PCR kit, with the aid of the 7300 Real-
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time PCR system (ABI, Foster City, CA, USA). PCR primers for human β-actin, IL-8 and TNF-
α were purchased from Qiagen. 
Transient transfection and luciferase reporter assay. For experiments using HEK293T cells, 
transfection was performed using the calcium phosphate method. For experiments using AGS 
cells, either calcium phosphate or Lipofectamine 2000 was used to transfect cells (Invitrogen). 
For luciferase assay, cells were lysed in passive lysis buffer 30 hours post-transfection; firefly 
and renilla luciferase activities were measured with the dual luciferase assay system from 
Promega. Firefly luciferase activity was normalized to renilla luciferase activity. Results 
represent the average of three independent experiments ± s.d. 
Establishment of cell lines stably expressing TRAF6 shRNA. The TRAF6-specific short 
hairpin RNA oligomer (5’-GGAGAAACCTGTTGTGATT-3’) was subcloned into the pSUPER-
retro-neo vector (Oligoengine). The vector was transfected into Phoenix-Ampho packaging cells 
and the supernatants were collected 48 h after transfection and used to infect AGS cells in the 
presence of 10 μg/ml polybrene (Sigma) for 24 h. After changing the medium, cells were 
cultured for 16 h and then selected with 0.5 mg/ml G418 (Sigma) for 7 days. The knock-down 
efficiency was assessed by immunoblotting. 
 
4.3 Results 
We first sought to determine the ubiquitin-conjugating enzyme required for TAK1 
ubiquitination. Only a few E2s have been found to play roles in catalyzing K63-linked 
ubiquitination, including Ubc13 which pairs with either Uev1a or Mms2, and potentially UbcH7 
(David et al., 2010; Geetha et al., 2005). An ubiquitination assay for TAK1 was performed in 
293Ts overexpressing TAK1, ubiquitin, and CagA after Ubc13, Uev1a and UbcH7 were first 
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knocked down with siRNA. Reduced ubiquitination of TAK1 was seen when Ubc13 and Uev1a 
were knocked down, suggesting that these E2s are required for the ubiquitination of TAK1 (Fig. 
4.2). Because Ubc13 and Uev1a typically work together, with neither capable of conjugating 
ubiquitin alone (David et al., 2010), further studies were performed investigating Ubc13 alone. 
Knock down of Ubc13 in AGS cells reduced the ubiquitination of TAK1 induced by H. pylori 
infection, further confirming the role which Ubc13 plays in H. pylori-induced TAK1 
ubiquitination (Fig. 4.3).  
Figure 4.2. Ubc13 and Uev1a likely work together as the E2 ubiquitin conjugating enzyme 
for TAK1. siRNA against different E2 enzymes were transfected into 293T cells, then TAK1 
was overexpressed along with HA-ubiquitin and CagA. Anti-Flag immunoprecipitates were 
immunoblotted for HA. 
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After determining that Ubc13 is required for the ubiquitination of TAK1 in response to 
H. pylori infection, we were interested to see whether knock down of the E2 diminished the 
CagA-mediated and the H. pylori-induced activation of TAK1 and NF-B. First, 293T cells were 
transfected with TAK1, CagA, and increasing amounts of a dominant negative form of Ubc13, 
Ubc13C87A (Deng et al., 2000). Luciferase activity was measured 30 hours post-transfection. 
When the dominant negative form of Ubc13 was co-transfected, TAK1-stimulated NF-B 
activity and CagA-enhanced TAK1-NF-B activity were both decreased in a dose-dependent 
fashion (Fig. 4.4A). Next, CagA-induced TAK1 autophosphorylation was investigated with and  
Figure 4.3. Ubc13 is required for H. pylori-induced ubiquitination of 
TAK1. AGS cells expressing Flag-TAK1 were infected as indicated with 
H. pylori. Flag immunoprecipitates were immunoblotted for ubiquitin. 
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without Ubc13C87A. Co-transfection of the dominant-negative Ubc13 severely diminished 
CagA-enhanced TAK1 phosphorylation (Fig. 4.4B). Lastly, Ubc13 was knocked down in AGS 
cells, cells were infected with H. pylori, and HA-TAK1 was immunoprecipitated from the cells. 
Autophosphorylation of TAK1 was detected using -TAK1 T187 antibodies. In cells with 
Ubc13 knocked down there was less autophosphorylation of TAK1 and less TAK1 kinase 
Figure 4.4. Ubc13 is required for CagA-dependent H. pylori-induced TAK1 and NF-B 
activity. A IL-8-luciferase, Renilla, and TAK1 were expressed in 293T cells with and without 
CagA along with increasing amounts of Ubc13C87A. Luciferase activity was assayed as in 
Fig. 3.6C. B TAK1 and CagA were expressed in 293T cells with or without Ubc13C87A. 
HA-TAK1 immunoprecipitates were immunoblotted for phosphorylated TAK1. C AGS cells 
expressing TAK1 and either control or Ubc13 siRNA were infected with H. pylori as 
indicated. HA-TAK1 immunoprecipitates were immunoblotted for phosphorylated TAK1. 
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activity in response to H. pylori infection than in cells where a control siRNA was transfected 
(Fig 4.4C).  
NF-B activation in Ubc13 knock-down cells was also investigated. When Ubc13 was 
knocked down and cells were infected with H. pylori, p65 and IB phosphorylation was 
reduced as detected by Western blotting of cell lysates, indicating a reduced capacity to activate 
NF-B (Fig. 4.5A). When Ubc13 was knocked down and cells were infected with H. pylori, 
luciferase assays and RT-PCR showed significantly less NF-B transcription activity than cells 
Figure 4.5. Ubc13 is important for H. pylori-induced NF-B activation. AGS cells were 
transfected with control or Ubc13 siRNA, then infected with H. pylori as indicated. A 
Lysates were immunoblotted as stated. B Cells were infected with H. pylori for 6 hrs, then 
lysates were assayed for luciferase activity. C mRNA was collected from cells and RT-PCR 
was performed to determine NF-B gene transcription. 
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transfected with a siRNA control (Fig. 4.5B & C). All together these data show that Ubc13 is not 
only required for TAK1 ubiquitination, but is also required for the activation of NF-B by H. 
pylori infection.  
Others have reported that the ubiquitination of TAK1 effected by TGF- or TNF- 
stimulation requires E3 ligase TRAF6, an E3 ligase whose activity first hinted at a role for 
ubiquitination in the activation of TAK1 (Wang et al., 2001). To determine whether TRAF6 was 
the E3 responsible for CagA-induced ubiquitination of TAK1, we first assessed the effect of a 
dominant-negative mutant of TRAF6 (TRAF6-DN; (Jono et al., 2004) on the polyubiquitination 
of TAK1. TRAF6-DN not only blocked the ubiquitination of TAK1, but also inhibited the 
enhanced ubiquitination of TAK1 facilitated by CagA (Fig 4.6A). The ability of CagA to 
enhance TAK1-mediated NF-B activation was also inhibited by TRAF6-DN (Fig 4.6B), 
indicating that ubiquitination of TAK1 is crucial for its activation.  
Figure 4.6. Dominant-negative TRAF6 blocks CagA-enhanced TAK1 ubiquitination and 
activation of NF-B. A 293T cells were transfected as indicated. Flag-TAK1 
immunoprecipitates were immunoblotted for HA-ubiquitin. B 293T cells were transfected for 
IL-8-luciferase assay as indicated. 30hrs post-transfection, lysates were assayed for luciferase 
assay. 
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To analyze further the role of TRAF6 in H. pylori-induced ubiquitination of TAK1 and 
NF-B activation, we generated an AGS cell line stably expressing short hairpin RNA (shRNA) 
against TRAF6 and examined the ubiquitination of TAK1 in these cells. H. pylori-induced 
Figure 4.7. TRAF6 is required for H. pylori-induced TAK1 ubiquitination and NF-
B activation. AGS stably transfected with TRAF6 shRNA were infected with H. pylori as 
indicated. A TAK1 immunoprecipitates were immunoblotted for ubiquitin. B RT-PCR was 
performed to measure NF-B target gene transcription. 
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ubiquitination of TAK1 and mRNA expression of IL-8 and TNF- were markedly attenuated in 
the TRAF6-depleted cells compared with AGS cells stably expressing control shRNA (Fig 4.7A 
& B). These data demonstrate that ubiquitination of TAK1 is crucial for CagA-enhanced NF-B 
activation and that TRAF6 is likely the E3 ubiquitin ligase for H. pylori-induced TAK1 
ubiquitination. 
 
4.4 Discussion 
 Around forty E2 ubiquitin conjugating enzymes have been found within the human 
genome. E2s are easily distinguished by the Ubc domains found in their protein sequences. Many 
participate in the synthesis of lysine 48-linked ubiquitin chains to target proteins for degradation 
by the proteasome. Only a few have been found to play a role in synthesis of other types of 
ubiquitin polymers, including lysine 63-linked, lysine 11-linked, and linear ubiquitin chains. 
Studies suggest that linkage specificity may be determined either by an E2 alone or by E2-E3 
combinations in vivo (Ye and Rape, 2009). The orientation of the next ubiquitin molecule to be 
added towards the last-added ubiquitin molecule is believed to be the determining factor in chain 
linkage specificity, and structural evidence continues to support this model. 
 Ubc13 is one of only a handful of E2s capable of catalyzing K63-linked ubiquitin chains, 
and one of the most well-studied. In addition to activation of the NF-B signaling pathway, K63-
linked ubiquitination is also involved in DNA damage response pathways and regulation of 
lysosomal degradation processes (David et al., 2010). This wide variety of functions makes 
modulation of K63-linked ubiquitination a potentially useful target for anti-cancer or immune-
regulatory therapeutics. While K63-linked ubiquitination is a relatively newly discovered 
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modification, future studies may show that its regulation may be as important a target for new 
therapies as phosphorylation or acetylation are currently. 
Although CagA enhances TRAF6-mediated Lys 63-linked ubiquitination of TAK1, it is 
not clear how this occurs. CagA fails to enhance the interaction between TRAF6 and TAK1 
(Appendix Fig. A.1), excluding the possibility that CagA might function as a bridging factor to 
facilitate the TAK1–TRAF6 interaction. It is possible that CagA could target TRAF6 and 
enhance its E3 ligase activity. Supporting this argument, we found that CagA also interacts with 
TRAF6 in vitro and enhances its auto-ubiquitination (Appendix Fig. A.2 & A.3). CagA is 
associated with the membrane when it enters the host cell, and has been shown to oligomerize 
(Higashi et al., 2005; Ren et al., 2006). It is possible that this oligomerization recruits TRAF6 
which enhances its E3 ligase activity and thus the ubiquitination of TAK1. Further supporting 
this, our data shows that oligomerization-deficient CagA does not activate NF-κB (Fig. 2.5). 
Another possibility is that CagA may inhibit deubiquitination by A20 or CYLD, two de-
ubiquitinases (DUBs) shown to remove ubiquitin chains from TRAF6 and TAK1 (Boone et al., 
2004; Kovalenko et al., 2003; Reiley et al., 2007), thereby enhancing the overall ubiquitination 
of TAK1. CagA may physically interfere with these DUBs, or may affect their NF-B-regulated 
expression. Future studies should examine these possibilities. 
How the ubiquitination of TAK1 activates the kinase is also unclear. It is expected that, 
like other K63-linked ubiquitinated signaling molecules, the polyubiquitin chain functions as a 
scaffold to recruit other signaling molecules which are essential for the activation of TAK1. For 
example, MEKK3 has been shown to be recruited to the ubiquitinated TAK1, and this 
recruitment is required for the activation of TAK1 (Yamazaki et al., 2009). Also, TAK1 
ubiquitination may aid in its activity by recruiting substrates, such as the IKK complex. The 
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ubiquitin-binding domain of the regulatory subunit NEMO has been shown to be important in the 
activation of IKK (Adhikari et al., 2007), and it may be that it binds to the ubiquitin chains on 
TAK1. TAK1 binding proteins TAB2 and TAB3 contain novel zinc fingers which bind 
specifically to K63-linked ubiquitin chains (Kanayama et al., 2004). Ubiquitination of TAK1 
may allow for the recruitment of other TAK1-TAB2/3 complexes, and the interaction of multiple 
complexes allows for cross-activation of TAK1. Another possibility is that TAK1 ubiquitination 
simply changes the conformation of the kinase, allowing for its activation. 
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CHAPTER 5 
POST-TRANSLATIONAL MODIFICATIONS OF NF-B ARE IMPORTANT FOR 
HELICOBACTER PYLORI-INDUCED INFLAMMATION 
 
5.1 Introduction 
NF-B is a tightly controlled transcription factor, with many levels of regulation. While 
we have mainly focused on the upstream pathways which lead to NF-B activity, its regulation 
once it reaches the nucleus is just as important. Many factors have been discovered to contribute 
to the transcriptional activation of NF-κB target genes, including the binding of different homo- 
or heterodimers of NF-κB to the cognate κB sites, the recruitment of various basal transcriptional 
factors and coactivators to the promoters, and the modifications of the histone tails around the 
promoters of NF-κB target genes (Chen and Greene, 2004). Recent studies indicate that 
posttranslational modifications of NF-κB, especially of the RelA subunit, play a critical role in 
fine-tuning the transcriptional activity of NF-κB, adding another important layer of complexity 
to the transcriptional regulation of NF-κB. 
A role for phosphorylation of RelA in the regulation of NF-κB activity has long been 
suggested (Baeuerle and Baltimore, 1996). Accordingly, many kinases and phosphorylation sites 
including, S276, S311, and S536, have been identified. RelA can be phosphorylated both in the 
cytoplasm and in the nucleus in response to a variety of stimuli. Most of the phosphorylation 
sites are within the N-terminal RHD and the C- terminal transcriptional activation domains. 
Phosphorylation of these sites often results in increased levels of transcription, though decreased 
transcription may also result, depending on the sites of phosphorylation, the target genes, and the 
stimuli. 
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Acetylation is another important posttranslational modification of RelA that has been 
extensively studied over the years. Different from phosphorylation, acetylation mostly occurs in 
the nucleus, where most of the enzymes mediating this modification reside. These enzymes 
include histone acetyltransferases and histone deacetylases, which mediate the addition or 
removal of the acetyl group to and from lysine residues. Reversible acetylation of RelA regulates 
diverse functions of NF-κB, including DNA binding activity, transcriptional activity, and its 
ability to associate with IκBα, and plays important roles in the NF-κB-mediated inflammatory 
response and cancer. Seven acetylated lysines have been identified within RelA, including 
lysines 122, 123, 218, 221, 310, 314 and 315. The majority of these lysines are acetylated by 
p300/CBP, but some lysines, like 122 and 123, can be acetylated by PCAF as well (Kiernan et 
al., 2003). Acetylation of these different lysines modulates distinct functions of NF-κB. 
Finally, lysine methylation has recently emerged as another important modification for 
the regulation of nuclear NF-κB function. The functional consequence of methylation depends 
on both position and state of the methylation site, since lysine can be mono-, di-, or tri-
methylated. Several methyltransferases have been identified to methylate RelA and regulate 
distinct functions of NF-κB. For example, SET7/9 specifically monomethylates RelA at K314 
and K315 in vitro and in vivo (Yang et al., 2009b). TNF-α- or LPS-induced methylation of RelA 
by Set9 negatively regulates the function of NF-κB by inducing the ubiquitination and 
degradation of promoter-bound RelA, which represents a novel mechanism by which NF-B 
transactivation can be turned off. 
Although many of the above mentioned studies using biochemical and molecular 
approaches have demonstrated that various posttranslational modifications of RelA regulate 
distinct biological functions, especially the transcriptional activation of NF-κB, the physiological 
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significance of these modifications is still being investigated. Nevertheless, a growing number of 
studies have linked various posttranslational modifications to a variety of disease conditions, 
especially inflammatory diseases and cancer. For example, phosphorylation of RelA on S276 or 
S536 is important for polymicrobial infection-induced lung inflammation (Kweon et al., 2006). 
Viruses, such as respiratory syncytial virus, also stimulate the phosphorylation of RelA 
(Jamaluddin et al., 2009). Anti-inflammatory drugs, such as licochalcone A, which act by 
inhibiting phosphorylation of RelA, may prove this modification to be an important target 
(Furusawa et al., 2009). Additionally, activation of NF-κB by different pathogens is often 
associated with hyperacetylation of NF-κB. H. influenzae (NTHi) induces the acetylation of 
RelA, and this acetylation is essential for NTHi-induced NF-κB activation and inflammation 
(Ishinaga et al., 2007; Ishinaga et al., 2009). Pathogens including Mycobacterium tuberculosis, 
M. leprae, Candida albicans, measles virus, and human immunodeficiency virus-1 (HIV), trigger 
DC-SIGN and induce acetylation of RelA, resulting in both prolonged and increased IL-10 
transcription to enhance the anti-inflammatory cytokine response (Gringhuis et al., 2007). 
Hyperacetylated RelA has been found in many cancer cells, and acetylation might account for 
the constitutively active NF-κB in cancer cells (Dai et al., 2005). A compound shown to mediate 
antitumor and anti-inflammatory activities, anacardic acid, has been found to inhibit NF-B 
acetylation by p300 histone acetyltransferase (Sung et al., 2008). Clearly, modulating NF-B 
activity at the level of posttranslational modifications could prove a promising new field for 
cancer and anti-inflammatory therapeutics. 
NF-B posttranslational modifications are induced by numerous pathogens resulting in 
chronic activation of the transcription factor. Thus, we were interested to determine whether H. 
pylori infection might also affect posttranslational modifications of NF-B. If so, therapeutics 
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targeted against these modifications might prove useful to down regulate H. pylori-induced 
chronic inflammation and cancer. 
 
5.2 Materials and Methods 
Cell lines, H. pylori culture and infection. Human AGS gastric adenocarcinoma and MEF cells 
were cultured in DMEM supplemented with 10% fetal bovine serum. H. pylori G27 was cultured 
in bisulphite-free Brucella broth on agar media containing Ham's F-12 medium supplemented 
with 10% fetal bovine serum and 5 μg/ml vancomycin at 37°C in the presence of 10% CO2. H. 
pylori was added to AGS cells for infection at a multiplicity of infection of 50–100. 
Quantitative real-time PCR analysis. AGS cells were infected with H. pylori for various times 
and total RNA was extracted using the RNeasy Mini kit (Qiagen, Valencia, CA, USA). 
Complementary DNA was synthesized using the Omniscript RT kit (Qiagen). Quantitative real-
time PCR was performed using the Qiagen SYBR green PCR kit, with the aid of the 7300 Real-
time PCR system (ABI, Foster City, CA, USA). PCR primers for human β-actin, IL-8 and TNF-
α were purchased from Qiagen. 
siRNA knock down and luciferase assay. Brd4 siRNA from Ambion was transfected into AGS 
cells using Lipofectamine 2000 according to the manufacturer’s protocol. For luciferase reporter 
assays, calcium phosphate was used to transfect cells. Cells were lysed in passive lysis buffer 30 
hours post-transfection; firefly and renilla luciferase activities were measured with the dual 
luciferase assay system from Promega. Firefly luciferase activity was normalized to renilla 
luciferase activity. Results represent the average of three independent experiments ± s.d. 
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5.3 Results 
In previous chapters we have demonstrated that H. pylori CagA activates the 
phosphorylation of p65 at serine 536 (Fig. 2.6). An interplay exists between phosphorylation at 
S536 and acetylation of RelA, in that phosphorylation enhances the binding of the histone 
acetyltransferase p300, providing enhanced acetylation of lysine 310, another modification for 
the positive regulation of NF-B activity (Huang et al., 2010)(Huang et al, 2010). We therefore 
decided to explore whether acetylation of RelA plays a role in H. pylori activation of NF-B. 
First, AGS cells treated with trichostatin A (TSA), a histone deacetylase (HDAC) inhibitor, were 
infected with H. pylori. NF-B-driven luciferase activity was measured, and inhibition of 
HDACs sensitive to TSA increased the H. pylori-induced activation of NF-B (Fig. 5.1).  
Figure 5.1. Histone deacetylase inhibitor TSA enhances NF-B 
activation by H. pylori. AGS cells were transfected with IL-8-
luciferase and renilla. 30 hrs post-transfection cells were treated 
with increasing doses of TSA and infected with H. pylori for 8 
hours. Luciferase activity was measured and normalized to renilla.  
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Recently, acetylation of p65 at K310 was found to upregulate NF-B gene transactivation 
by recruiting a co-factor, Brd4, which recruits and activates the RNA polymerase II kinase 
CDK9, a crucial step in transcription activation (Huang et al., 2009). We therefore sought to 
determine whether Brd4 recruitment to K310 might play a role in H. pylori transactivation of 
NF-B. Brd4 was knocked down in AGS cells using siRNA, then cells were infected with H. 
pylori and NF-B target gene mRNA was measured with RT-PCR. NF-B activation by H. 
pylori was significantly decreased when Brd4 was knocked down as compared with a control 
(Fig. 5.2). 
 Brd4 binds to acetylated p65 through its two bromodomains, domains recognized for 
their ability to specifically recognize acetylated lysine, and the interaction is required for Brd4 to 
recruit CDK9 to the promoter-bound NF-B transcriptional complex (Huang et al., 2009). To 
explore whether this specific interaction is required for H. pylori-induced NF-B activity, we 
treated cells with a newly-identified cell-permeable small molecule inhibitor of bromodomain-
containing factors, JQ1 (Filippakopoulos et al., 2010). JQ1 and DMSO treated AGS cells were 
Figure 5.2. Brd4 is required for H. pylori-induced NF-B activation. AGS cells were 
transfected with Brd4 siRNA or control siRNA. Cells were infected with H. pylori for 
indicated times, and mRNA was harvested for RT-PCR. 
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infected with H. pylori, and NF-B target gene mRNA was detected using RT-PCR. Cells 
treated with JQ1 showed significantly less NF-B target gene transcription than control cells 
(Fig. 5.3). Since JQ1 binds the acetyl-lysine binding pocket of Brd4, as shown by x-ray 
crystallography (Filippakopoulos et al., 2010), our findings suggest that interaction between 
acetylated p65 and Brd4 is required for H. pylori-induced NF-B activation. 
 
5.4 Discussion 
Post-translational modifications of NF-B elaborate a “transcription factor code” much 
like the “histone code” proposed by Strahl and Allis in 2000 (Strahl and Allis, 2000). Regulation 
of the transcriptional activity of NF-B can be achieved by the addition or removal of a number 
of molecules including phosphorylation, methylation, and acetylation. These modifications allow 
for co-factors of NF-B to bind, dissociate, or promote further modifications which may increase 
or decrease transcription activity.  
Figure 5.3. Small molecule JQ1 inhibits H. pylori-induced NF-B activation. 5mM JQ1 or 
DMSO was added to AGS cells 30 min before H. pylori were added. Cells were infected 
with H. pylori for indicated times, and mRNA was harvested for RT-PCR. 
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HDACs inhibited by TSA may be involved in deacetylation of many different sites 
within NF-B or in deacetylation of the histones which are part of the chromatin near NF-B 
target genes; therefore, it is possible that a site other than K310 may be acetylated in response H. 
pylori infection, or that inhibition of histone deacetylation may lead to the results I found. Since 
acetylation of histone tails typically results in activation of chromatin rather than suppression, the 
decreased transcriptional activity observed in the presence of TSA is more likely to be due to 
decreased acetylation of NF-B. Seven lysines within NF-B have been identified as acetylation 
sites. The negative effect of the HDAC inhibitor on H. pylori-induced NF-B activity suggests 
that acetylation of sites which result in positive modulation of NF-B activity are targets in H. 
pylori infection. Acetylation of K221 or K310, for example, enhance transcriptional activity of 
NF-B (Chen et al., 2002). Besides these, acetylation of K314 and K315 may direct activation of 
specific target genes (Buerki et al., 2008; Rothgiesser et al., 2010). 
Whether these modifications are specifically targeted by a H. pylori virulence factor is 
not known. While CagA appears to be necessary at least for phosphorylation (Fig. 2.6), it may be 
that it sets in motion a specific pathway of activations that includes certain pre-determined 
modifications required for full activation of the transcription factor, or for activation of a specific 
subset of NF-B target genes. Another possibility is that CagA directly activates kinases, 
acetylases, or other enzymes required for post-translational activation of NF-B. Since CagA 
singles out TAK1 in the upstream activation pathway of NF-B, it is not impossible for it to also 
target downstream enzymes in this process. CagA is known to be a widely functioning protein, 
and has been seen in the nucleus of infected cells, the site of many post-translational 
modifications, by our lab. 
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Chronic activation of NF-B, a regulator of inflammation and an inhibitor of apoptosis, is 
a hallmark of many cancers, and targeting NF-B pathways to inhibit growth or induce apoptosis 
of these cancers may be a therapeutically useful goal. In this respect, small molecules such as 
JQ1, which are found to inhibit NF-B by blocking co-factor binding to post-translational 
modifications of NF-B, may be important in the future. Understanding the roles of post-
translational modifications of transcription factors, and their regulation in normal and disease 
states, may be a critical piece of information for the treatment of cancers and other 
dysregulation-caused diseases. 
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CHAPTER 6 
DISCUSSION 
 
Helicobacter pylori infection is one of the leading factors for the development of gastric 
carcinoma. Infection with this common bacterium is often chronic, thriving for decades in the 
stomach of its host. Such a long incubation time allows for many changes to accumulate as a 
result of this interaction, and even small changes, such as subclinical inflammation, can cause 
great problems over a lifetime. Studying the pathways through which H. pylori virulence factors 
cause cellular or tissue changes, or activate signaling pathways such as the NF-B, will be 
instrumental in better understanding host-pathogen interactions and also developing a better 
understanding of the ways in which inflammatory pathways are regulated. 
In my studies, I found that CagA is required for activation of NF-B during H. pylori 
infection. Infection of gastric epithelial cells with wild-type H. pylori, but not CagA-deficient H. 
pylori, enhanced NF-B activity in luciferase assays and when NF-B-dependent target gene 
mRNA was measured. Furthermore, various activating post-translational modifications of NF-
B are induced by H. pylori infection, including phosphorylation and acetylation. CagA likely 
activates NF-B via upstream signaling through TRAF6- and Ubc13-mediated ubiquitination of 
TAK1, a kinase involved in phosphorylation and activation of the IKK complex. These studies 
have shed a great deal of light on the mechanisms involved in stimulation of the inflammatory 
pathways by H. pylori, and have opened new doors for better understanding of this host-
pathogen interaction. 
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While our studies clearly demonstrate the importance of TAK1 ubiquitination and TAK1 
activity in CagA-dependent H. pylori-mediated NF-κB activation, studies from others also 
suggest that other molecules might be targeted by CagA and involved in CagA-dependent NF-κB 
activation. Suzuki et al. reported that CagA interacted with the hepatocyte growth factor receptor 
Met, resulting in the activation of PI3K and Akt, which led to the activation of NF-κB and β-
catenin (Suzuki et al., 2009). Since CagA binds Met, an intramembrane protein, and is also 
known to oligomerize, this binding and oligomerization may also lead to the recruitment of 
TRAF6. TRAF6 is recruited to the membrane by the dimerization of other membrane receptors, 
and it dimerizes in turn and becomes an active E3 ubiquitin ligase (Sun et al., 2004), which we 
found to be required for the ubiquitination of TAK1 (Fig. 4.7). Akt was also recently found to be 
ubiquitinated by TRAF6, which proved important for its phosphorylation and activation (Yang et 
al., 2009a). Although a role for Akt has been suggested in the activation of NF-κB by H. pylori 
(Suzuki et al., 2009; Takeshima et al., 2009), how Akt activates NF-κB is not clear. Akt might 
activate IKK directly or indirectly through TAK1, or Akt might activate NF-κB by inducing the 
phosphorylation of RelA. While TAK1 is activated in vitro by binding to unanchored ubiquitin 
(Xia et al., 2009), Akt might function as a kinase for the in vivo phosphorylation and activation 
of TAK1. It is also possible that Akt may act in conjunction with TAK1 to fully activate the IKK 
complex via phosphorylation of IKK1/2. 
Although CagA enhances TRAF6-mediated Lys 63-linked ubiquitination of TAK1 (Fig. 
3.5), it is not clear how this occurs. CagA fails to enhance the interaction between TRAF6 and 
TAK1 (Appendix Fig. A.1), excluding the possibility that CagA might function as a bridging 
factor to facilitate the TAK1–TRAF6 interaction. It is possible that CagA could target TRAF6 
and enhance its E3 ligase activity or prevent TAK1 from interacting with deubiquitination 
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enzymes such as CYLD or A20, which remove ubiquitination and reduce activation of TAK1 
(Reiley et al., 2007). Alternatively, CagA may prevent K48-linked ubiquitination by XIAP or 
Itch, preventing the turnover of the active enzyme, resulting in enhanced TAK1 activity (Ahmed 
et al., 2011; Kaur et al., 2005). It may also be possible that CagA interacts with the Ubc13 E2 
enzyme complex, enhancing its activity or promoting its interaction with TRAF6 for the 
ubiquitination of TAK1. Further investigation into the mechanism of CagA-enhanced TAK1 
K63-linked ubiquitination and activation would greatly enhance our understanding not only of H. 
pylori infection-induced activation of this NF-B pathway, but would also help us understand the 
role and regulation of K63-linked ubiquitination more broadly. 
Interestingly, TAK1 is involved in nearly every pathway that is activated by H. pylori, 
including the JNK, ERK and p38 MAPK pathways (Keates et al., 1999). We suggest that our 
CagA-dependent mechanism of activation for TAK1 in the NF-κB pathway may also contribute 
to the downstream activations of these other pathways, furthering our understanding of the role 
which CagA plays in host cells. Determining the precise way by which CagA stimulates the 
TRAF6-dependent ubiquitination and activation of TAK1 would clarify the H. pylori-induced 
inflammatory response, and would provide new information that could be used to combat 
development of the diseases linked to H. pylori infection. 
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APPENDIX 
 
 
Figure A.1. CagA does not affect the interaction 
between TAK1 and TRAF6. HEK293T cells were 
transfected as indicated. T7-TRAF6 was 
immunoprecipitated, and immunoprecipitates were 
immunoblotted as indicated. Expression levels of each 
protein are shown in the lower three panels. 
Figure A.2. CagA interacts with TRAF6 in vitro. GST 
and GST-CagA were used to pull-down in vitro-
translated TRAF6. Pull-downs were separated by SDS-
PAGE and TRAF6 was detected by autoradiography. 
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Figure A.3. CagA enhances the ubiquitination of 
TRAF6. HEK293T cells were transfected as indicated. 
T7-TRAF6 immunoprecipitates were immunoblotted for 
HA-ubiquitin and T7-TRAF6 as indicated. Levels of 
Flag-CagA are shown in the lower panel. 
